These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11520421)

  • 1. Universal leucocyte-depletion of blood components: cell concentrates and plasma.
    Engelfriet CP; Reesink HW; Pietersz RN; Schwartz DW; Mayr WR; Blajchman MA; Goldman M; Décary F; Sher G; Georgsen J; Sprogøe-Jakobsen U; Kekomäki R; Kühnl P; Seitz R; Maniatis A; Pintér J; Baróti K; Shinar E; Rebulla P; Greppi N; Sirchia G; Faber JC; Flanagan P; Brand A; Lêtowska M; Nel T; Argelagues E; Martin-Vega C; AuBuchon JP; Williamson L; Wallington T
    Vox Sang; 2001 Jul; 81(1):56-77. PubMed ID: 11520421
    [No Abstract]   [Full Text] [Related]  

  • 2. Universal WBC reduction.
    Nightingale SD;
    Transfusion; 2001 Oct; 41(10):1306-9. PubMed ID: 11606833
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma components: FFP, FP24, and thawed plasma.
    Eder AF; Sebok MA
    Immunohematology; 2007; 23(4):150-7. PubMed ID: 18284305
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leukocyte filtration of stored whole blood for preparation of components].
    Riggert J; Simson G; Dittmann J; Wieding JU; Köhler M
    Beitr Infusionsther Transfusionsmed; 1994; 32():1-5. PubMed ID: 9480063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.
    O'Mahony B; Turner A
    Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based recommendations for the use of WBC-reduced cellular blood components.
    Ratko TA; Cummings JP; Oberman HA; Crookston KP; DeChristopher PJ; Eastlund DT; Godwin JE; Sacher RA; Yawn DH; Matuszewski KA;
    Transfusion; 2001 Oct; 41(10):1310-9. PubMed ID: 11606834
    [No Abstract]   [Full Text] [Related]  

  • 7. Universal leucocyte reduction of blood components: a need for evidence-based decision making.
    Farrugia A
    Dev Biol (Basel); 2002; 108():113-20. PubMed ID: 12220134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell salvage and leucodepletion.
    Cross MH
    Perfusion; 2001 Mar; 16 Suppl():61-6. PubMed ID: 11334209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storage and handling of blood components – perspectives.
    Hervig T; Kaada SH; Seghatchian J
    Transfus Apher Sci; 2014 Oct; 51(2):103-106. PubMed ID: 25457749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International blood collection and storage: clinical use of blood products.
    Greening DW; Glenister KM; Sparrow RL; Simpson RJ
    J Proteomics; 2010 Jan; 73(3):386-95. PubMed ID: 19664733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitating blood component preparation: the impact of overnight room temperature storage.
    McLaughlin LS; Moroff G; Benjamin RJ
    Transfusion; 2010 Feb; 50(2):278-80. PubMed ID: 20088837
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of leucocyte depletion on the generation and removal of microvesicles and prion related protein in blood components.
    Krailadsiri P; Perry R; Drummond O; Smith K; Hockley D; Seghatchian J; Spring F; Macgregor I; Williamson L; Prowse C; Lubenko A; Anstee D; Barrowcliffe T; Turner M
    Transfus Apher Sci; 2001 Dec; 25(3):177-8. PubMed ID: 11846133
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components.
    Murphy MF
    Transfus Sci; 1998 Dec; 19(4):343-6. PubMed ID: 10351149
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukodepleted blood components: definition of a standard.
    Andreu G; Masse M; Royer SD; Tardivel R
    Transfus Sci; 1998 Dec; 19(4):381-3. PubMed ID: 10351163
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality control of leucocyte-reduced blood components: overestimation of WBC content due to nucleated red blood cells.
    Fischer JC; Moog R; Giers G
    Vox Sang; 2012 Jan; 102(1):79-81. PubMed ID: 21564108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation approaches selective/universal leucodepletion: the need for standardised validation strategies.
    Seghatchian MJ; Krailadsiri P
    Transfus Sci; 1998 Dec; 19(4):363-5. PubMed ID: 10351157
    [No Abstract]   [Full Text] [Related]  

  • 17. Military walking blood bank and the civilian blood service.
    Berséus O; Hervig T; Seghatchian J
    Transfus Apher Sci; 2012 Jun; 46(3):341-2. PubMed ID: 22475543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on leucocyte depletion of blood components by filtration.
    Pietersz RN; van der Meer PF; Seghatchian MJ
    Transfus Sci; 1998 Dec; 19(4):321-8. PubMed ID: 10351145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of blood products in shock.
    Nacht A
    Crit Care Clin; 1992 Apr; 8(2):255-91. PubMed ID: 1568140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials in Transfusion Medicine and hemotherapy: Worth moving forward in evaluating 'fresh' versus 'old' blood cell components?
    Garraud O
    Transfus Apher Sci; 2017 Feb; 56(1):98-99. PubMed ID: 28117175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.